CARY, N.C.--(BUSINESS WIRE)--SciQuest, Inc., (NASDAQ: SQI) a provider of on-demand source-to-settle solutions, today announced the appointment of Charles Irek to vice president, technology. Irek brings more than 20 years of experience in the software development industry to SciQuest. He has successfully led multiple early-stage software firms to commercial offerings and revenue capture, and has also managed technology development at IBM and GlaxoSmithKline. In his role as vice president of technology, Irek will be responsible for all development and infrastructure resources behind SciQuest’s suite of collaborative, SaaS-based source-to-settle solutions.
“Charles brings a highly successful track record in software development to direct the SciQuest technology team,” said Stephen Wiehe, president and CEO of SciQuest. “Charles’ extensive experience leading software development organizations and his entrepreneurial background make him the ideal choice for leading the development of innovative products that help support the overall success of our customers.”
Before joining SciQuest, Irek was the CTO and VP of Software Engineering for Diagnosoft Inc., a point-of-care healthcare analytics company. While at Diagnosoft, he was able to expand the company’s product offering by more than 300 percent while building essential vendor relationships and forming strategic partnerships with vital advisors. He also served as vice president of software engineering for Proventys, Inc. where he was responsible for building and leading the company’s software development capability.
“I’m looking forward to working with the SciQuest team and expanding its already impressive software and technology,” said Irek. “I believe that my adaptive leadership and management style, together with some of the brightest minds in the industry, will help enhance the company’s software platform with new value-added features that will drive our customers’ businesses.”
For an in-depth Q&A with Charles Irek and to learn more about his plans for SciQuest’s software development team, please visit The Open Kitchen – http://www.sciquest.com/blog/.
About SciQuest
SciQuest (NASDAQ: SQI) provides organizations with a comprehensive suite of on-demand source-to-settle software solutions, driving cost and efficiency savings across the supply chain. By improving supplier management, negotiating more strategic contracts, generating an online marketplace for purchasing goods and services, and streamlining the accounts payable process, SciQuest customers turn spending into a source of savings.
With unmatched visibility into spending, combined with the Power of Q — the Company’s unique combination of products and support — SciQuest provides organizations with a strategic approach to procurement, improving bottom-line results.
To join the conversation, please visit our blog, The Open Kitchen—http://www.sciquest.com/blog or follow us on Twitter @SciQuest.
Cautionary Note Regarding Forward-Looking Statements
Any statements in this release that are not historical or current facts are forward-looking statements. All forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. Certain of these risks and uncertainties are described in the “Risk Factors” section of our Registration Statement on Form S-1 and other required reports, as filed with the SEC, which are available free of charge on the SEC’s website at http://www.sec.gov or on our website at www.sciquest.com. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results. These forward-looking statements speak only as of the date hereof, and we undertake no obligation to update, amend or clarify any forward-looking statement for any reason.